NPI: 1720277866 · BAKERSFIELD, CA 93309 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/15/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 10/15/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 82,220 | $4.84M |
| 2019 | 63,814 | $3.71M |
| 2020 | 43,347 | $2.65M |
| 2021 | 38,683 | $2.53M |
| 2022 | 26,788 | $1.84M |
| 2023 | 22,018 | $2.05M |
| 2024 | 9,059 | $1.04M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 108,495 | 8,582 | $17.88M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 71,890 | 5,047 | $293K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 759 | 222 | $159K |
| J1756 | Injection, iron sucrose, 1 mg | 24,574 | 5,545 | $142K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,757 | 905 | $64K |
| J1270 | Injection, doxercalciferol, 1 mcg | 49,724 | 4,191 | $51K |
| A4657 | Syringe, with or without needle, each | 11,108 | 3,628 | $40K |
| 90747 | 118 | 91 | $10K | |
| 90674 | 335 | 291 | $8K | |
| J1644 | Injection, heparin sodium, per 1000 units | 255 | 26 | $5K |
| 90662 | 99 | 91 | $3K | |
| 90732 | 15 | 15 | $1K | |
| 83970 | 2,691 | 2,148 | $1K | |
| 85041 | 2,685 | 2,266 | $578.64 | |
| G0008 | Administration of influenza virus vaccine | 131 | 104 | $509.34 |
| 82728 | 2,157 | 1,685 | $262.41 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 350 | 222 | $254.37 |
| 85048 | 2,665 | 2,252 | $212.90 | |
| 83540 | 2,140 | 1,681 | $198.86 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,776 | 180 | $101.58 |
| 83550 | 1,777 | 1,330 | $78.06 | |
| 0250 | 299 | 24 | $0.00 | |
| 82108 | 129 | 95 | $0.00 |